Vollständiger Abstract
Worum geht es in dieser Arbeit?
Graft-versus-host disease (GvHD) remains the mainly cause of late non-relapse mortality following allogeneic hematopoietic cell transplantation. Advancements in novel immunosuppressive therapies and prophylactic regimens necessitate an update to current clinical guidance. This consensus provides updated evidence-based recommendations for GVHD prophylaxis, alongside the treatment of acute and chronic disease.
Bibliografischer Nachweis
Publikationsdaten
- Autor:innen
- Vaneuza Araújo Moreira Funke, João Victor Piccolo Feliciano, Giancarlo Fatobene, Maria Cláudia Rodrigues Moreira, Antonio Vaz de Macedo, Rita de Cássia Barbosa da Silva Tavares, Marcia de Matos Silva, Marcos Paulo Colella, Morgani Rodrigues, Luis Fernando da Silva Bouzas, Afonso Celso Vigorito
- Quelle
- JOURNAL OF BONE MARROW TRANSPLANTATION AND CELLULAR THERAPY
- Publikation
- 2026-01-01
- Band / Ausgabe
- Nicht angegeben
- Seiten
- Nicht angegeben
- ISSN / ISBN
- 2675-374X
- Zitationen
- 0 laut Crossref
- Referenzen
- 0 hinterlegt
Zitieren
Zitierfähiger Nachweis
Vaneuza Araújo Moreira Funke, João Victor Piccolo Feliciano, Giancarlo Fatobene, Maria Cláudia Rodrigues Moreira, Antonio Vaz de Macedo, Rita de Cássia Barbosa da Silva Tavares, Marcia de Matos Silva, Marcos Paulo Colella, Morgani Rodrigues, Luis Fernando da Silva Bouzas, Afonso Celso Vigorito (2026). Consensus on graft-versus-host disease. JOURNAL OF BONE MARROW TRANSPLANTATION AND CELLULAR THERAPY. https://doi.org/10.46765/2675-374x.2025v7n1e361
Kontext
Themen, Förderung und Nutzung
Lizenzhinweise: Lizenz 1